Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
2025 Revenue of $18.9 Million Exceeded Outlook with a Record 40 Scanners Shipped Affirms 2026 Revenue Guidance of $39 Million from Contracted Scanner MOQs and Initial QTI Cloud Platform Revenue Advances Transition to a SaaS- and Biomarker-Driven Medical Imaging Platform Conference Call Begins Today at 4:30 p.m. Eastern Time QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and twelve months ended December 31, 2025 and provided a business update. "I am proud of the transformation QT Im
Allows for Commercial Deployment of the Company's Radiation-Free Breast Imaging Technology Under Distribution Agreement with Al Naghi Medical Co., Supports $24 Million Revenue Pipeline Through 2028 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the United Arab Emirates (UAE) Emirates Drug Establishment (EDE) for use as a medical device in that country. This clearance allows for the importation and distribution of our scanner t
QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the three and 12 months ended December 31, 2025 after market close on Wednesday, March 25, 2026 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time: Wednesday, March 25, 4:30 p.m. ET / 1:30 p.m. PT Pre-Registration: Participants can pre-register for the conference call here: Callers who pre-register will be given a conference passcode and uniqu
8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
POS AM - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
POS AM - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th Streamlined Business Model via Strategic Sales and Distribution Partnership in USA Reported in Academic Radiology the Results of a Second Blinded Screening Trial That Found That QTI Technology Is Similarly Effective as Digital Breast Tomosynthesis (DBT) or 3D Mammography Company Completed Merger with GigCapital5 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first qu
2025 Revenue of $18.9 Million Exceeded Outlook with a Record 40 Scanners Shipped Affirms 2026 Revenue Guidance of $39 Million from Contracted Scanner MOQs and Initial QTI Cloud Platform Revenue Advances Transition to a SaaS- and Biomarker-Driven Medical Imaging Platform Conference Call Begins Today at 4:30 p.m. Eastern Time QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and twelve months ended December 31, 2025 and provided a business update. "I am proud of the transformation QT Im
QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the three and 12 months ended December 31, 2025 after market close on Wednesday, March 25, 2026 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time: Wednesday, March 25, 4:30 p.m. ET / 1:30 p.m. PT Pre-Registration: Participants can pre-register for the conference call here: Callers who pre-register will be given a conference passcode and uniqu
Generated Record Revenue of $8.3 Million in Q4 2025, up 97% versus Q3 2025 Shipped Record 17 Scanners in Q4 2025 and 40 in 2025, up from 12 Scanners Shipped in 2024 Exceeded 2025 Sales Outlook, Delivering Revenue of $18.9 Million Relisted on Nasdaq Less Than One Year After Leaving the Exchange Continues to Pivot from a Scanner Company to a SaaS and Biomarker-Driven Medical Imaging Franchise QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company") a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announces preliminary unaudited financial results for the fourth quarter and full year
SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)
SC 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)
SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)